About

Phytomenadione Injection is a synthetic form of Vitamin K1 used to treat and prevent bleeding disorders caused by Vitamin K deficiency. It is commonly administered in cases of anticoagulant overdose, liver diseases, or conditions impairing Vitamin K absorption. In newborns, it prevents hemorrhagic disease, reducing bleeding risks. Phytomenadione promotes blood clotting by aiding the synthesis of clotting factors (II, VII, IX, and X) in the liver. The injection is given intramuscularly or intravenously under medical supervision. It is essential in veterinary and human medicine for managing coagulation disorders effectively. Proper dosage and monitoring ensure safety and efficacy in treatment.

Mechanism and Benefits of Phytomenadione Injection

Phytomenadione (Vitamin K1) acts by promoting the synthesis of clotting factors, making it integral to haemostasis. Its primary benefit is in preventing and treating bleeding disorders such as hypoprothrombinemia and Vitamin K deficiency, particularly in neonates and individuals on anticoagulant therapy.


Flexible Administration Routes for Tailored Care

The injection can be given intramuscularly, intravenously, or orally, allowing healthcare providers to select the most appropriate route for each patients clinical needs. This flexibility ensures optimal absorption and effectiveness across varied age groups and medical scenarios.


Safe Storage and Handling Information

To maintain its efficacy, the injection must be stored below 25C and protected from light. This preservative-free formulation reduces the risk of additional sensitivities, making it suitable for even sensitive individuals, including neonates.